NCT04642183View on ClinicalTrials.gov

Single In-Clinic Encounter With the Notal Vision Home OCT

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

November 16, 2020

Primary Completion Date

August 24, 2021

Study Completion Date

September 30, 2021

Conditions
Neovascular Age-related Macular DegenerationIntermediate Age Related Macular Degeneration (Disorder)
Trial Locations (1)

21237

Elman Retina Group, PA, Baltimore

Sponsors

Lead Sponsor

Notal Vision Inc.
All Listed Sponsors
lead

Notal Vision Inc.

INDUSTRY

NCT04642183 - Single In-Clinic Encounter With the Notal Vision Home OCT | Biotech Hunter | Biotech Hunter